| pubmed-article:15514170 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:15514170 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
| pubmed-article:15514170 | lifeskim:mentions | umls-concept:C0038454 | lld:lifeskim |
| pubmed-article:15514170 | lifeskim:mentions | umls-concept:C0199176 | lld:lifeskim |
| pubmed-article:15514170 | lifeskim:mentions | umls-concept:C1522577 | lld:lifeskim |
| pubmed-article:15514170 | lifeskim:mentions | umls-concept:C1510802 | lld:lifeskim |
| pubmed-article:15514170 | lifeskim:mentions | umls-concept:C1704686 | lld:lifeskim |
| pubmed-article:15514170 | lifeskim:mentions | umls-concept:C1521828 | lld:lifeskim |
| pubmed-article:15514170 | lifeskim:mentions | umls-concept:C0175668 | lld:lifeskim |
| pubmed-article:15514170 | pubmed:issue | 12 | lld:pubmed |
| pubmed-article:15514170 | pubmed:dateCreated | 2004-11-26 | lld:pubmed |
| pubmed-article:15514170 | pubmed:abstractText | The Stroke PROTECT (Preventing Recurrence Of Thromboembolic Events through Coordinated Treatment) program systematically implements, at the time of acute transient ischemic attack (TIA) or ischemic stroke admission, 8 medication/behavioral secondary prevention measures known to improve outcome in patients with cerebrovascular disease. The objective of this study was to determine if the high utilization rates previously demonstrated at hospital discharge were maintained at 90 days after discharge. | lld:pubmed |
| pubmed-article:15514170 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15514170 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15514170 | pubmed:language | eng | lld:pubmed |
| pubmed-article:15514170 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15514170 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:15514170 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:15514170 | pubmed:month | Dec | lld:pubmed |
| pubmed-article:15514170 | pubmed:issn | 1524-4628 | lld:pubmed |
| pubmed-article:15514170 | pubmed:author | pubmed-author:KidwellChelse... | lld:pubmed |
| pubmed-article:15514170 | pubmed:author | pubmed-author:SaverJeffrey... | lld:pubmed |
| pubmed-article:15514170 | pubmed:author | pubmed-author:FredieuAndreA | lld:pubmed |
| pubmed-article:15514170 | pubmed:author | pubmed-author:SuzukiShuichi... | lld:pubmed |
| pubmed-article:15514170 | pubmed:author | pubmed-author:OvbiageleBruc... | lld:pubmed |
| pubmed-article:15514170 | pubmed:author | pubmed-author:SelcoScottS | lld:pubmed |
| pubmed-article:15514170 | pubmed:author | pubmed-author:RajajeeVenkat... | lld:pubmed |
| pubmed-article:15514170 | pubmed:author | pubmed-author:McNairNormaN | lld:pubmed |
| pubmed-article:15514170 | pubmed:author | pubmed-author:RaziniaTannaz... | lld:pubmed |
| pubmed-article:15514170 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:15514170 | pubmed:volume | 35 | lld:pubmed |
| pubmed-article:15514170 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:15514170 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:15514170 | pubmed:pagination | 2879-83 | lld:pubmed |
| pubmed-article:15514170 | pubmed:dateRevised | 2007-11-15 | lld:pubmed |
| pubmed-article:15514170 | pubmed:meshHeading | pubmed-meshheading:15514170... | lld:pubmed |
| pubmed-article:15514170 | pubmed:meshHeading | pubmed-meshheading:15514170... | lld:pubmed |
| pubmed-article:15514170 | pubmed:meshHeading | pubmed-meshheading:15514170... | lld:pubmed |
| pubmed-article:15514170 | pubmed:meshHeading | pubmed-meshheading:15514170... | lld:pubmed |
| pubmed-article:15514170 | pubmed:meshHeading | pubmed-meshheading:15514170... | lld:pubmed |
| pubmed-article:15514170 | pubmed:meshHeading | pubmed-meshheading:15514170... | lld:pubmed |
| pubmed-article:15514170 | pubmed:meshHeading | pubmed-meshheading:15514170... | lld:pubmed |
| pubmed-article:15514170 | pubmed:meshHeading | pubmed-meshheading:15514170... | lld:pubmed |
| pubmed-article:15514170 | pubmed:meshHeading | pubmed-meshheading:15514170... | lld:pubmed |
| pubmed-article:15514170 | pubmed:meshHeading | pubmed-meshheading:15514170... | lld:pubmed |
| pubmed-article:15514170 | pubmed:meshHeading | pubmed-meshheading:15514170... | lld:pubmed |
| pubmed-article:15514170 | pubmed:meshHeading | pubmed-meshheading:15514170... | lld:pubmed |
| pubmed-article:15514170 | pubmed:meshHeading | pubmed-meshheading:15514170... | lld:pubmed |
| pubmed-article:15514170 | pubmed:year | 2004 | lld:pubmed |
| pubmed-article:15514170 | pubmed:articleTitle | In-hospital initiation of secondary stroke prevention therapies yields high rates of adherence at follow-up. | lld:pubmed |
| pubmed-article:15514170 | pubmed:affiliation | Stroke Center and Department of Neurology, University of California at Los Angeles, 710 Westwood Plaza, Los Angeles, CA 90095, USA. Ovibes@mednet.ucla.edu. | lld:pubmed |
| pubmed-article:15514170 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:15514170 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
| pubmed-article:15514170 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| pubmed-article:15514170 | pubmed:publicationType | Research Support, N.I.H., Extramural | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15514170 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15514170 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15514170 | lld:pubmed |
